TotalMarketCap

China Pharma

CPHINYSE ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$23.537 M

$0.55 -6.88%

Close of 6 Nov 2026

As of 6 Nov 2026, China Pharma (CPHI) has a market capitalization of $23.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.14M

#3301 by revenue

Earnings

-$3.19M

Loss-making

Shares outstanding

43,022,002

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #374CelularityCELU$23.7M
  2. #375NextCureNXTC$23.6M
  3. #376China PharmaCPHI$23.5M
  4. #377Mira PharmaceuticalsMIRA$23.0M
  5. #378CervoMedCRVO$22.7M

What if China Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$656,335.66

Per share 1,199,663× higher

Bitcoin $1.53T

$35,513.18

Per share 64,912× higher

Apple $5.02T

$116,586.45

Per share 213,099× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for China Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.